한글목차

Demerol Meperdine의 동향과 예측

세계의 Demerol Meperdine 시장은 2024-2030년의 CAGR이 3.1%로, 2030년까지 추정 4억 달러에 달할 것으로 예측됩니다. 이 시장의 주요 촉진요인은 약물전달 시스템의 진보와 함께 시판 진통제의 비용 대 효과가 높은 것, 환자 의식이 높아지고 있는 것, 효과적인 통증 관리 솔루션이 입수 가능한 것입니다. 세계의 Demerol Meperdine 시장은 진통, 마취, 기침 억제제, 탈중독의 각 시장에서의 기회에 의해 미래가 유망시되고 있습니다.

Demerol Meperdine 시장 인사이트

Lucintel의 예측에서 급성통 및 격통의 치료에 도움이 되는 것으로 인해 예측 기간 중 비경구약이 계속 큰 부문을 차지합니다.

이 시장내에서는 급성 및 만성 통증성 질환의 발생에 의해 진통제가 가장 높은 성장을 달성할 것으로 예측됩니다.

북미는 왕성한 헬스케어 지출과 만성 통증에 대한 대응 요구의 증가로 인해 예측 기간 중에도 최대 지역을 유지할 것으로 생각됩니다.

아래 11개의 주요 질문에 답변하고 있습니다. :

• Q.1.시장 부문 중 가장 유망하고 고성장인 기회는 무엇인가?
• Q.2.어느 부문이 보다 빠른 페이스로 성장하는가, 또 이유는?
• Q.3.향후 성장이 가속할 것으로 생각되는 지역과 이유는?
• Q.4.시장 역학에 영향을 미치는 주요 요인은 무엇인가? 시장에서 주요 과제와 비즈니스 리스크는?
• Q.5.이 시장에서 비즈니스 리스크와 경쟁의 위협은?
• Q.6.이 시장에서 새로운 동향과 이유는?
• Q.7.시장에서 고객의 수요 변화에는 어떤 것이 있는가?
• Q.8.이 시장에서 새로운 개발과 개발을 선도하고 있는 기업은?
• Q.9.이 시장의 주요 기업은? 주요 기업은 사업 성장을 위해 어떤 전략적 구상을 진행시키고 있는가?
• Q.10.이 시장에서 경쟁 제품은 무엇이며, 재료 및 제품의 대체에 의한 시장 점유율 하락의 위협은 어느 정도인가?
• Q.11.과거 5년간 어떤 M&A가 시행되고, 업계에 어떤 영향을 미쳤는가?

목차

제1장 주요 요약

제2장 세계의 Demerol Meperdine 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계의 촉진요인과 과제

제3장 2018-2030년의 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 Demerol Meperdine 시장 동향(2018-2023)과 예측(2024-2030)
• 제품 유형별 세계의 Demerol Meperdine 시장
  • 비경구
  • 정제
• 용도별 세계의 Demerol Meperdine 시장
  • 진통제
  • 마취
  • 기침 억제
  • 설사 억제
  • 탈의존증

제4장 2018-2030년의 지역별 시장 동향과 예측 분석

• 지역별 세계의 Demerol Meperdine 시장
• 북미의 Demerol Meperdine 시장
• 유럽의 Demerol Meperdine 시장
• 아시아태평양Demerol Meperdine 시장
• 기타 지역의 Demerol Meperdine 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상의 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 제품 유형별 세계의 Demerol Meperdine 시장의 성장 기회
  • 용도별 세계의 Demerol Meperdine 시장의 성장 기회
  • 지역별 세계의 Demerol Meperdine 시장의 성장 기회
• 세계의 Demerol Meperdine 시장의 새로운 동향
• 전략적 분석
  • 신제품의 개발
  • 세계의 Demerol Meperdine 시장의 능력 확대
  • 세계의 Demerol Meperdine 시장에서의 합병, 인수, 합병사업
  • 인증과 라이선싱

제7장 유력 기업의 기업 개요

• Actavis
• Sun Pharmaceuticals
• Sanofi
• Boehringer Ingelheim
• Pfizer
• Janssen Pharmaceuticals
• Egalet Corporation

영문목차

Demerol Meperdine Trends and Forecast

The future of the global demerol meperdine market looks promising with opportunities in the pain relief, anesthesia, cough suppression, and diarrhea suppression and de-addiction markets. The global demerol meperdine market is expected to reach an estimated $0.4 billion by 2030 with a CAGR of 3.1% from 2024 to 2030. The major drivers for this market are cost-effectiveness of over-the-counter (otc) analgesic drugs, coupled with advancements in drug delivery systems, rising patient awareness, and availability of effective pain management solutions.

A more than 150-page report is developed to help in your business decisions.

Demerol Meperdine by Segment

The study includes a forecast for the global demerol meperdine by product type, application, and region.

Demerol Meperdine Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Parenteral
• Tablets

Demerol Meperdine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Pain Relief
• Anesthesia
• Cough Suppression
• Diarrhea Suppression
• De-Addiction

Demerol Meperdine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Demerol Meperdine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies demerol meperdine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the demerol meperdine companies profiled in this report include-

• Actavis
• Sun Pharmaceuticals
• Sanofi
• Boehringer Ingelheim
• Pfizer
• Janssen Pharmaceuticals
• Egalet Corporation

Demerol Meperdine Market Insights

Lucintel forecasts that parenteral will remain the larger segment over the forecast period as it helps in treating acute and severe pain.

Within this market, pain relief is expected to witness the highest growth due to occurence of acute and chronic painful disorders.

North America will remain the largest region over the forecast period due to strong healthcare expenditure and rising need to deal with chronic pain in the region.

Features of the Global Demerol Meperdine Market

Market Size Estimates: Demerol meperdine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Demerol meperdine market size by product type, application, and region in terms of value ($B).

Regional Analysis: Demerol meperdine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, applications, and regions for the demerol meperdine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the demerol meperdine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the demerol meperdine market size?

Answer: The global demerol meperdine market is expected to reach an estimated $0.4 billion by 2030.

Q2. What is the growth forecast for demerol meperdine market?

Answer: The global demerol meperdine market is expected to grow with a CAGR of 3.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the demerol meperdine market?

Answer: The major drivers for this market are cost-effectiveness of over-the-counter (otc) analgesic drugs, coupled with advancements in drug delivery systems, rising patient awareness and availability of effective pain management solutions.

Q4. What are the major segments for demerol meperdine market?

Answer: The future of the demerol meperdine market looks promising with opportunities in the pain relief, anesthesia, cough suppression, and diarrhea suppression and de-addiction markets.

Q5. Who are the key demerol meperdine market companies?

Answer: Some of the key demerol meperdine companies are as follows:

• Actavis
• Sun Pharmaceuticals
• Sanofi
• Boehringer Ingelheim
• Pfizer
• Janssen Pharmaceuticals
• Egalet Corporation

Q6. Which demerol meperdine market segment will be the largest in future?

Answer: Lucintel forecasts that parenteral will remain the larger segment over the forecast period as it helps in treating acute and severe pain.

Q7. In demerol meperdine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to strong healthcare expenditure and rising need to deal with chronic pain in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the demerol meperdine market by product type (parenteral and tablets), application (pain relief, anesthesia, cough suppression, diarrhea suppression, and de-addiction), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Demerol Meperdine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Demerol Meperdine Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Demerol Meperdine Market by Product Type
  • 3.3.1: Parenteral
  • 3.3.2: Tablets
• 3.4: Global Demerol Meperdine Market by Application
  • 3.4.1: Pain Relief
  • 3.4.2: Anesthesia
  • 3.4.3: Cough Suppression
  • 3.4.4: Diarrhea Suppression
  • 3.4.5: De-addiction

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Demerol Meperdine Market by Region
• 4.2: North American Demerol Meperdine Market
  • 4.2.2: North American Demerol Meperdine Market by Application: Pain Relief, Anesthesia, Cough Suppression, Diarrhea Suppression, and De-addiction
• 4.3: European Demerol Meperdine Market
  • 4.3.1: European Demerol Meperdine Market by Product Type: Parenteral and Tablets
  • 4.3.2: European Demerol Meperdine Market by Application: Pain Relief, Anesthesia, Cough Suppression, Diarrhea Suppression, and De-addiction
• 4.4: APAC Demerol Meperdine Market
  • 4.4.1: APAC Demerol Meperdine Market by Product Type: Parenteral and Tablets
  • 4.4.2: APAC Demerol Meperdine Market by Application: Pain Relief, Anesthesia, Cough Suppression, Diarrhea Suppression, and De-addiction
• 4.5: ROW Demerol Meperdine Market
  • 4.5.1: ROW Demerol Meperdine Market by Product Type: Parenteral and Tablets
  • 4.5.2: ROW Demerol Meperdine Market by Application: Pain Relief, Anesthesia, Cough Suppression, Diarrhea Suppression, and De-addiction

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Demerol Meperdine Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Demerol Meperdine Market by Application
  • 6.1.3: Growth Opportunities for the Global Demerol Meperdine Market by Region
• 6.2: Emerging Trends in the Global Demerol Meperdine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Demerol Meperdine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Demerol Meperdine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Actavis
• 7.2: Sun Pharmaceuticals
• 7.3: Sanofi
• 7.4: Boehringer Ingelheim
• 7.5: Pfizer
• 7.6: Janssen Pharmaceuticals
• 7.7: Egalet Corporation